These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Valvular heart disease and primary pulmonary hypertension associated with fenfluramine-phentermine]. Wolf I; Mouallem M; Farfel Z Harefuah; 1998 Dec; 135(11):515-7. PubMed ID: 10911468 [No Abstract] [Full Text] [Related]
25. The fen-phen controversy: is regression another piece of the puzzle? Asinger RW Mayo Clin Proc; 1999 Dec; 74(12):1302-4. PubMed ID: 10593359 [No Abstract] [Full Text] [Related]
34. A dangerous duo? A combination of common diet drugs (fen-phen) may lead to heart valve disease. Boughner DR CMAJ; 1997 Sep; 157(6):705-6. PubMed ID: 9307558 [No Abstract] [Full Text] [Related]
35. Appetite-suppressant drugs and valvular heart disease. Shapiro S N Engl J Med; 1999 Feb; 340(6):477-8; author reply 478-80. PubMed ID: 9988622 [No Abstract] [Full Text] [Related]
36. Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine: U.S. Department of Health and Human Services interim public health recommendations, November 1997. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1997 Nov; 46(45):1061-6. PubMed ID: 9385873 [TBL] [Abstract][Full Text] [Related]
40. Fen/phen and valvular heart disease: if it sounds too bad to be true, perhaps it isn't. Schiller NB J Am Coll Cardiol; 1999 Oct; 34(4):1159-62. PubMed ID: 10520806 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]